United States

People: Discover Financial Services (DFS.N)

DFS.N on New York Stock Exchange

23 Oct 2017
Change (% chg)

$0.27 (+0.41%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Aronin, Jeffrey 

Mr. Jeffrey S. Aronin is Independent Director of Discover Financial Services. Mr. Aronin is chairman and chief executive officer of Paragon Pharmaceuticals, a global development and biopharmaceutical investment firm, and is chairman and chief executive officer of Marathon Pharmaceuticals, a research based prescription biopharmaceutical company. From 2000 to 2009, Mr. Aronin was president and chief executive officer of Ovation Pharmaceuticals Inc., a biopharmaceutical company he founded in 2000. In 2009, Ovation Pharmaceuticals was acquired by Lundbeck, Inc. Mr. Aronin served as president and chief executive officer of Lundbeck, Inc. in 2009 during its acquisition and integration of Ovation Pharmaceuticals. He is the former chairman and chief executive officer at MedCare Technologies Inc., a publicly held healthcare company. Mr. Aronin has experience as a chief executive officer leading a global pharmaceutical company. His skills include strategic and business development, finance and marketing. He brings valuable leadership experience and knowledge in the operations and day-to-day management of a global corporation in a regulated industry. Mr. Aronin also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions.

Basic Compensation

Total Annual Compensation, USD 100,000
Restricted Stock Awards, USD 129,955
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 229,955

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --